173 related articles for article (PubMed ID: 3732364)
1. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
3. Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administration.
Jones TE; Milne RW; Mudaliar Y; Sansom LN
Antimicrob Agents Chemother; 1985 Aug; 28(2):293-8. PubMed ID: 3834835
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
[TBL] [Abstract][Full Text] [Related]
5. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis.
Gross ML; Somani P; Ribner BS; Raeader R; Freimer EH; Higgins JT
Clin Pharmacol Ther; 1983 Nov; 34(5):673-80. PubMed ID: 6313276
[TBL] [Abstract][Full Text] [Related]
6. Moxalactam epimer disposition in patients undergoing continuous ambulatory peritoneal dialysis.
Morse G; Janicke D; Cafarell R; Piontek K; Apicella M; Jusko WJ; Walshe J
Clin Pharmacol Ther; 1985 Aug; 38(2):150-6. PubMed ID: 4017417
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis.
Demotes-Mainard F; Vinçon G; Ragnaud JM; Morlat P; Bannwarth B; Dangoumau J
J Clin Pharmacol; 1993 May; 33(5):475-9. PubMed ID: 8331207
[TBL] [Abstract][Full Text] [Related]
8. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.
Somani P; Shapiro RS; Stockard H; Higgins JT
Clin Pharmacol Ther; 1982 Jul; 32(1):113-21. PubMed ID: 7083725
[TBL] [Abstract][Full Text] [Related]
9. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis.
Keller E; Jansen A; Pelz K; Hoppe-Seyler G; Schollmeyer P
Clin Pharmacol Ther; 1984 Feb; 35(2):208-13. PubMed ID: 6692648
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
Ryckelynck JP; Debruyne D; Hurault De Ligny B; Moulin M
Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
[TBL] [Abstract][Full Text] [Related]
14. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis.
Mendes P; Lameire N; Rosenkranz B; Malerczyk V; Damm D
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():89-93. PubMed ID: 2074257
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal absorption of moxalactam.
Stephens NM; Kronfol NO; Kline BJ; Polk RE
Antimicrob Agents Chemother; 1983 Jul; 24(1):39-41. PubMed ID: 6625555
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.
Arvidsson A; Alván G; Tranaeus A; Malmborg AS
Eur J Clin Pharmacol; 1985; 28(3):333-7. PubMed ID: 4007038
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
Johnson CA; Zimmerman SW; Bayer W; Craig WA
Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
